The NEUPRO Transdermal Patch (Rotigotine) is a medicated patch used to treat Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. Parkinson's disease (PD) is a neurodegenerative disorder that can cause tremors, slow movement, stiffness, and balance problems. Restless Legs Syndrome is a disorder that causes you to want to move your legs. As a result of long-term RLS, you may feel unpleasant sensations such as aching, burning, itching, throbbing, or tugging. NEUPRO Transdermal Patch (Rotigotine) is classified as adopamine agonist. Fact Table Formula C19H25NOS License US DailyMed, EU EMA Bioavailability 37% Legal status Rx-Only Chemical Name Rotigotine Elimination half-life 5–7 hours Dosage (Strength) 1mg - 8mg (24 hours patches) Pregnancy Consult Doctor Brands Neupro Protein binding 92% PubChem CID 57537 MedlinePlus a607059 ChEBI 135351 ATC code N04BC09 DrugBank DB05271 KEGG D05768 Routes of administration Transdermal patch

Neupro Transdermal Patch (Rotigotine)

For Parkinson's disease, NEUPRO Transdermal Patch (Rotigotine) dosages range from 2 mg/24 hours to 8 mg/24 hours. For Restless Legs Syndrome, NEUPRO Transdermal Patch (Rotigotine) dosages range from 1 mg/24 hours to 3 mg/24 hours. NEUPRO should be applied to clean, dry, and undamaged skin once a day. It should be held firmly in place for 30 seconds. The patch should not be placed where it could be rubbed by clothing. Do not place the patch on the same site of skin more than once every 14 days.
NEUPRO contains sodium metabisulfite which can cause allergic reactions in people who are sensitive to sulfite. Falling asleep or drowsiness during daily activities may occur. Hallucinations or psychosis may occur. A symptomatic drop in blood pressure upon sitting or standing up may occur, especially during dosage increases. Fainting may also occur. Anincrease in blood pressureor heart rate may occur. If you experience compulsive behaviors, consider decreasing the dose or stopping NEUPRO. You may experience a very high fever and confusion if you suddenly stop NEUPRO or decrease the dose. Withdrawal symptoms such asanxiety,depression, tiredness, trouble sleeping, sweating, and pain have been reported when decreasing dosages or after stopping NEUPRO.
If you experience any adverse effects while using the NEUPRO Transdermal Patch (Rotigotine), be sure to speak with your doctor. Common side effects of NEUPRO include: Application site reactions, Anorexia, Dizziness, Drowsiness, Dyskinesia, Excessive sweating, Headache, Nausea, Peripheral edema, Sleep problems, Vision problems, Vomiting References: Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients.Read More....

Neupro Transdermal Patch (Rotigotine)

Directions

Ingredients

Cautions

Side Effects